{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:57:17Z","timestamp":1792616237513,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.09.049","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:53:24Z","timestamp":1791320004000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infused CD34+ Cell Dose Predicts Response to Stem Cell Boost in Children with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study from the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)"],"prefix":"10.1016","author":[{"given":"Mar\u00eda Isabel","family":"Ben\u00edtez-Carabante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Ortiz-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Carbonell-Asins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Vinagre","family":"Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"Ur\u00eda-Oficialdegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmina Mozo","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n L\u00f3pez","family":"Torija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Sisinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes Plaza","family":"Fornieles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Urtasun-Erburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Fuentes","family":"Socorro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Garc\u00eda","family":"Culebras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Trabazo del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Fern\u00e1ndez","family":"Sojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Castillo-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Alonso","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Gonz\u00e1lez-Vicent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edaz-de-Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jtct.2026.09.049_bib0001","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41409-024-02248-9","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT","volume":"59","author":"Passweg","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.049_bib0002","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.049_bib0003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.09.049_bib0004","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbmt.2013.07.014","article-title":"Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kong","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.09.049_bib0005","series-title":"The EBMT Handbook","first-page":"365","article-title":"Graft failure","author":"Valc\u00e1rcel","year":"2024"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.049_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.seminhematol.2018.08.004","article-title":"Poor graft function after allogeneic hematopoietic stem cell transplantation\u2014an old complication with new insights","volume":"56","author":"Kong","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2026.09.049_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/2040620720948743","article-title":"Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation","volume":"11","author":"Chen","year":"2020","journal-title":"Ther Adv Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.049_bib0008","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.049_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","article-title":"Graft failure after allogeneic hematopoietic cell transplantation","volume":"14","author":"Mattsson","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.09.049_bib0010","doi-asserted-by":"crossref","first-page":"877.e1","DOI":"10.1016\/j.jtct.2021.07.012","article-title":"Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"27","author":"Shahzad","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.049_bib0011","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/10428194.2021.1872072","article-title":"Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation","volume":"62","author":"Prabahran","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0012","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.bbmt.2019.05.036","article-title":"Incidence, risk factors, and outcomes of primary poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Zhao","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.09.049_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101076","article-title":"Definitions, incidence and outcome of poor graft function after hematopoietic cell transplantation: a systematic review and meta-analysis","volume":"60","author":"M\u00fcskens","year":"2023","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.049_bib0014","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1182\/bloodadvances.2021004537","article-title":"Clinical features, pathophysiology, and therapy of poor graft function post\u2013allogeneic stem cell transplantation","volume":"6","author":"Prabahran","year":"2022","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.049_bib0015","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00277-019-03715-w","article-title":"Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation","volume":"98","author":"Sun","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2026.09.049_bib0016","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1080\/10428194.2020.1789622","article-title":"Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant","author":"Reich-Slotky","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0017","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/bmt.2016.98","article-title":"Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis","volume":"51","author":"Alchalby","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0018","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0301-472X(99)00076-4","article-title":"Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients","volume":"27","author":"Galotto","year":"1999","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jtct.2026.09.049_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911174","article-title":"Recent advancements in poor graft function following hematopoietic stem cell transplantation","volume":"13","author":"Man","year":"2022","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.049_bib0020","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/S1473-3099(25)00069-6","article-title":"Recommendations from the 10th European conference on infections in leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies","volume":"25","author":"Ljungman","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.jtct.2026.09.049_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70059","article-title":"Definitions matter: multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation","volume":"8","author":"M\u00fcskens","year":"2024","journal-title":"HemaSphere"},{"issue":"5","key":"10.1016\/j.jtct.2026.09.049_bib0022","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1705072","article-title":"Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders","volume":"36","author":"Bittencourt","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0023","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.bbmt.2019.05.023","article-title":"Thrombopoietin receptor agonists for severe thrombocytopenia after allogeneic stem cell transplantation: experience of the Spanish group of hematopoietic stem cell transplant","volume":"25","author":"Bento","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.049_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/bjh.15012","article-title":"CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation","volume":"180","author":"Mainardi","year":"2018","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3727\/096368912X661319","article-title":"Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study","volume":"23","author":"Liu","year":"2014","journal-title":"Cell Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.049_bib0026","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s12015-025-10903-x","article-title":"Outcomes following second allogeneic stem cell transplant for graft failure or poor graft function: a single centre experience","volume":"21","author":"Kim","year":"2025","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"10.1016\/j.jtct.2026.09.049_bib0027","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/sj.bmt.1705760","article-title":"Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation","volume":"40","author":"Jabbour","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.049_bib0028","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbmt.2013.11.034","article-title":"CD34+-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies","volume":"20","author":"Klyuchnikov","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2026.09.049_bib0029","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3324\/haematol.2019.226340","article-title":"Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function","volume":"105","author":"Cuadrado","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.049_bib0030","first-page":"112","article-title":"CD34+-selected stem cell \u201cboost\u201d for poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Mohty","year":"2019","journal-title":"Curr Res Transl Med"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.049_bib0031","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.09.049_bib0032","first-page":"183","article-title":"Documentation of engraftment and chimerism after HCT","author":"Bader","year":"2024","journal-title":"EBMT Handb Hematop Cell Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.049_bib0033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.049_bib0034","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0035","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.bbmt.2014.05.016","article-title":"CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation","volume":"20","author":"Stasia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.09.049_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1640546","article-title":"Autoimmune neutropenia: a rare complication of allogeneic hematopoietic stem cell transplantation?","volume":"16","author":"Ben\u00edtez Carabante","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.049_bib0037","doi-asserted-by":"crossref","first-page":"601.e1","DOI":"10.1016\/j.jtct.2024.03.019","volume":"30","author":"Ben\u00edtez Carabante","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.049_bib0038","first-page":"112","article-title":"CD34+-selected stem cell \u201cboost\u201d for poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"67","author":"Mohty","year":"2019","journal-title":"Curr Res Transl Med"},{"issue":"11","key":"10.1016\/j.jtct.2026.09.049_bib0039","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3324\/haematol.2019.226340","article-title":"Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function","volume":"105","author":"Cuadrado","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jtct.2026.09.049_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13909","article-title":"CD34+ selected peripheral blood stem cell boost (SCB) for poor graft function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: results of a retrospective multicenter study","volume":"25","author":"Berger","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.049_bib0041","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.jtct.2022.09.027","article-title":"Durable engraftment and excellent overall survival after CD34-selected peripheral blood stem cell boost in pediatric patients with poor graft function following allogeneic stem cell transplantation","volume":"29","author":"Fraint","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.jtct.2026.09.049_bib0042","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/bmt.2013.80","article-title":"Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone","volume":"48","author":"Sung","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.049_bib0043","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34\u202f+\u202fcell dose is associated with long-term platelet count recovery Following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.049_bib0044","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.049_bib0045","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.049_bib0046","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14010","article-title":"Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children","volume":"25","author":"Uria-Oficialdegui","year":"2021","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.09.049_bib0047","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12185-021-03153-3","article-title":"Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study","volume":"114","author":"Giammarco","year":"2021","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.049_bib0048","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-015-0155-5","article-title":"Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model","volume":"6","author":"Fern\u00e1ndez-Garc\u00eda","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jtct.2026.09.049_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1106464","article-title":"Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: a multicenter prospective analysis","volume":"14","author":"Servais","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2026.09.049_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1375493","article-title":"Mesenchymal stromal cells in the treatment of pediatric hematopoietic cell transplantation-related complications (graft vs. host disease, hemorrhagic cystitis, graft failure and poor graft function): a single center experience","volume":"12","author":"P\u00e9rez-Torres Lobato","year":"2024","journal-title":"Front Pediatr"},{"issue":"10","key":"10.1016\/j.jtct.2026.09.049_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31203","article-title":"CD3+TCR\u03b1\u03b2\/CD19+-depleted stem cell boost and CD45RO+ memory T-cell add-back as a successful salvage treatment for poor graft function unresponsive to eltrombopag, following a second allogenic HSCT","volume":"71","author":"Ramanathan","year":"2024","journal-title":"Pediatr Blood Cancer"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:27:52Z","timestamp":1792614472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726007803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S2666636726007803"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.049","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infused CD34+ Cell Dose Predicts Response to Stem Cell Boost in Children with Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Study from the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}